The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Amazon.com Inc. | COM | 023135106 | 925,236 | 3,882 | SH | SOLE | 3,882 | 0 | 0 | ||
| ArriVent BioPharma, Inc. | COM | 04272N102 | 51,928,866 | 1,494,786 | SH | SOLE | 1,494,786 | 0 | 0 | ||
| Carvana Co | CL A | 146869102 | 425,526 | 6,465 | SH | SOLE | 6,465 | 0 | 0 | ||
| Coupang Inc. | CL A | 22266T109 | 949,739 | 54,677 | SH | SOLE | 54,677 | 0 | 0 | ||
| Doordash Inc. | CL A | 25809K105 | 525,911 | 2,850 | SH | SOLE | 2,850 | 0 | 0 | ||
| Eikon Therapeutics, Inc. | COM | 282564103 | 3,983,291 | 305,233 | SH | SOLE | 305,233 | 0 | 0 | ||
| Ethos Technologies, Inc. | CL A | 29765A101 | 1,345,607 | 74,179 | SH | SOLE | 74,179 | 0 | 0 | ||
| Figma, Inc. | CLASS A COM STK | 316841105 | 268,546 | 14,845 | SH | SOLE | 14,845 | 0 | 0 | ||
| Fractyl Health, Inc. | COM | 35168W103 | 3,879,997 | 4,884,186 | SH | SOLE | 4,884,186 | 0 | 0 | ||
| Maplebear, Inc. | COM | 565394103 | 33,652,166 | 710,711 | SH | SOLE | 710,711 | 0 | 0 | ||
| Maze Therapeutics, Inc. | COM | 578784100 | 30,911,554 | 1,035,910 | SH | SOLE | 1,035,910 | 0 | 0 | ||
| Meta Platforms Inc. | CL A | 30303M102 | 743,543 | 1,320 | SH | SOLE | 1,320 | 0 | 0 | ||
| Odyssey Therapeutics, Inc. | COMMON STOCK | 67613T104 | 15,160,189 | 810,272 | SH | SOLE | 810,272 | 0 | 0 | ||
| Parabilis Medicines, Inc. | COM | 698955101 | 43,817,646 | 1,600,937 | SH | SOLE | 1,600,937 | 0 | 0 | ||